About Us
Neuregenix was founded in 2007 by Professor Martin Berry, Dr Zubair Ahmed and myself, three neuroscientists at the forefront of neurotrauma and neurodegeneration research, with an ambition to enhance the impact of our areas of research excellence. The last 11 years have confirmed and expanded that ambition.
As a niche CRO working in the neurological and ophthalmology research arenas, we now work with a team of world class experimental and clinical research scientists and opinion leaders to provide a range of drug discovery, preclinical drug screening and clinical trial services to the biotechnology and pharmaceutical industry worldwide.
The direct links forged between our scientists and our customers are the guarantee of a fruitful working relationship, reinforced by our recognised expertise, high staff motivation and quality of delivery.
